Prediction of overall survival after re-irradiation with stereotactic body radiation therapy for pancreatic cancer with a novel prognostic model (the SCAD score).
CONCLUSIONS: The SCAD score may have the potential to identify individuals benefiting from re-SBRT and be a step toward more personalized medicine.
PMID: 30217337 [PubMed - as supplied by publisher]
Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - Category: Radiology Authors: Zhu X, Li F, Ju X, Shen Y, Cao Y, Cao F, Fang F, Qing S, Jia Z, Zhang H Tags: Radiother Oncol Source Type: research
More News: Cancer | Cancer & Oncology | Pancreas | Pancreatic Cancer | Radiation Therapy | Radiology | Training | Universities & Medical Training